Open AccessBrain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events
Author(s) -
David W. Haas,
Yuki Bradford,
Anurag Verma,
Shefali S. Verma,
Joseph J. Eron,
Roy M. Gulick,
Sharon A. Riddler,
Paul E. Sax,
Eric S. Daar,
Gene D. Morse,
Edward P. Acosta,
Marylyn D. Ritchie
Publication year - 2018
Publication title -
pharmacogenetics and genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.579
H-Index - 140
eISSN - 1744-6880
pISSN - 1744-6872
DOI - 10.1097/fpc.0000000000000341
Subject(s) - efavirenz , adverse effect , biology , medicine , pharmacology , endocrinology , genetics , viral load , virus , antiretroviral therapy
We characterized associations between central nervous system (CNS) adverse events and brain neurotransmitter transporter/receptor genomics among participants randomized to efavirenz-containing regimens in AIDS Clinical Trials Group studies in the USA.